These data suggest that aberrant activation of hepatic NIK suppresses hepatocyte proliferation and liver regeneration in NAFLD at least in part by inhibiting the JAK2/STAT3 pathway. This evidence concerns the gene JAK2 and metabolic dysfunction-associated steatotic liver disease.